2022
DOI: 10.20944/preprints202202.0248.v1
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Lactobacilli Infection Case Reports in the Last Three Years and Safety Implications

Abstract: probiotics. However, these bacteria caused rare infections mostly in diabetic and immunocompromised subjects in presence of risk factors such as prosthetic hearth valves and dental procedures or caries. The scope of this survey was re-assessing the pathogenic potential of lactobacilli based on the infection case reports published in the last three years. In 2019, 2020 and 2021 17, 15 and 16 cases, respective-ly,.including endocarditis, bacteremia and other infections, were reported. These annual numbers are hi… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 9 publications
(1 citation statement)
references
References 45 publications
(114 reference statements)
0
1
0
Order By: Relevance
“…It is important to establish the appropriate target population. Individuals with pre-established health conditions that lead to compromised immune systems should not be eligible for use of probiotics in conjunction with antibiotic therapy (Rossi et al 2022).Resistance to adverse effects caused by gastrointestinal transit is also a criterion evaluated when choosing potentially probiotic strains, especially when the goal is to select probiotics with action on intestinal disorders. When other features and application forms are explored, as in the case of adjuvant action in the treatment of dysbiosis of the vaginal tract, this criterion is not so necessary (Chenoll et al 2019).…”
Section: Nucleic Acid Synthesis Inhibitorsmentioning
confidence: 99%
“…It is important to establish the appropriate target population. Individuals with pre-established health conditions that lead to compromised immune systems should not be eligible for use of probiotics in conjunction with antibiotic therapy (Rossi et al 2022).Resistance to adverse effects caused by gastrointestinal transit is also a criterion evaluated when choosing potentially probiotic strains, especially when the goal is to select probiotics with action on intestinal disorders. When other features and application forms are explored, as in the case of adjuvant action in the treatment of dysbiosis of the vaginal tract, this criterion is not so necessary (Chenoll et al 2019).…”
Section: Nucleic Acid Synthesis Inhibitorsmentioning
confidence: 99%